The maximum potential market for dengue drugs V 1.0

► Global economic burden of dengue was US $1.7 billion in 2006. ► Maximum potential market for dengue drugs is US $338 million per annum. ► Potential sales of a dengue drug exceed drug R + D costs. ► Dengue vaccines will not substantially impact potential sales of a dengue drug. ► Drug pricing based on shared division of economic costs is an alternative to tiered pricing.